Research Article Open Access

Isolation of the Antimicrobial Cyclic Peptide Subtilosin a from a Gut-Associated Bacillus subtilis Strain

Ghislain Schyns1, Claudia R. Serra2, Adriano O. Henriques2, AnthonyArguelles-Arias3, Bernard Joris3 and Patrick Fickers4
  • 1 DSM Nutritional Products, Ltd, Switzerland
  • 2 Universidade Nova de Lisboa, Portugal
  • 3 University of Liège, Belgium
  • 4 Université libre de Bruxelles, Belgium

Abstract

The endospore-forming Bacillus subtilis has been used as probiotics over the last 50 years. However, little is known on how Bacillus spp act in the gut compared to other well-characterized probiotics such as lactic acid bacteria. It is believed that the competitive exclusion of pathogens results from different mode of action notably the production of antimicrobial compounds such as bacteriocins. Here, we report the characterization of the unexpected ability of a gut-associated B. subtilis BSP1 to synthetize the cyclic bacteriocin subtilosin A at high level. Our findings suggest that the BSP1 phenotype could be related, at least in part, to a subsequent increased expression level of the subtilosin A biosynthetic gene cluster sbo-alb in response to a higher activity of the stationery and sporulation master regulator Spo0A.

American Journal of Biochemistry and Biotechnology
Volume 9 No. 3, 2013, 307-317

DOI: https://doi.org/10.3844/ajbbsp.2013.307.317

Submitted On: 17 April 2013 Published On: 21 September 2013

How to Cite: Schyns, G., Serra, C. R., Henriques, A. O., AnthonyArguelles-Arias, Joris, B. & Fickers, P. (2013). Isolation of the Antimicrobial Cyclic Peptide Subtilosin a from a Gut-Associated Bacillus subtilis Strain. American Journal of Biochemistry and Biotechnology, 9(3), 307-317. https://doi.org/10.3844/ajbbsp.2013.307.317

  • 3,920 Views
  • 3,236 Downloads
  • 1 Citations

Download

Keywords

  • Bacillus Subtilis
  • Bacteriocin
  • Subtilosin
  • Probiotic